Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment 2024-02-20 14:00
Innovent Announces Primary Endpoint Met in the Phase 3 Clinical Trial (RESTORE-1) of IBI311 (Anti-IGF-1R Antibody) in Treating Thyroid Eye Disease and Plans to Submit NDA to the NMPA 2024-02-20 08:22
HKUST Neuroscientists Develop Highly Accurate Universal Diagnostic Blood Test for Alzheimer's Disease and Mild Cognitive Impairment 2024-02-19 20:18
Neurophth Announces Completion of Patient Enrollment for Opvika® Phase I/II Clinical Trial in the U.S. 2024-02-19 19:30
SIBIONICS Announced to Exhibit at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) 2024-02-19 10:55
AffaMed Therapeutics Announces New Drug Application Acceptance by Singapore Health Sciences Authority (HSA) for DEXTENZA® for Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery, and Ocular Itching Associated with Allergic Conjunctivitis 2024-02-19 09:00
Everest Medicines Announces Termination of Collaboration Agreements with Providence 2024-02-19 08:20
SwiftMR™, Game-Changing AI-Powered MRI Solution Gears Up in ANZ Market: AIRS Medical Forges Strategic Partnership with ParagonCare 2024-02-19 06:00
Jacobio Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor 2024-02-18 20:50
China Medical University Hospital (CMUH) in Taiwan Upgrades Smart Healthcare with Gen AI 2024-02-17 21:30
New Study Demonstrates Predictive Value of Lunit SCOPE IO to Predict Outcomes of Immune Checkpoint Inhibitor Therapy Across Diverse Tumors - published in the JITC 2024-02-16 22:03
IFPA Releases an Innovative Psoriatic Care Roadmap and Action Playbook 2024-02-16 17:00
Kim Byoung Joon LEDAS Varicose Vein Clinic Becomes the First Organization to be Accredited under GHA Standards for Medical Travel 5.0 2024-02-15 19:00
Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED. 2024-02-15 17:05
Pharus Diagnostics Signs Worldwide Exclusive License Agreement with City of Hope for Novel Biomarkers to Be Used in Liquid Biopsy Screening for Early Pancreatic Cancer Diagnosis 2024-02-15 16:05
iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology 2024-02-15 11:37
STARmed to Accelerate Global Market Entry of EUSRA and ELRA Products through Olympus 2024-02-14 22:00
Sky Labs' CART BP Becomes the World's First to Complete Comparative Studies with All Blood Pressure Measurement Methods 2024-02-14 21:00
YS Biopharma Announces Appointment of New Directors 2024-02-14 20:50
GC Biopharma Presents Updates on its LSD Treatments at the WORLDSymposium 2024 2024-02-14 16:33
1 95 96 97 98 99 963